Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
COMPARATIVE ANALYSIS OF DIFFERENT PHENOTYPES IN CARDIOGENIC SHOCK: A REAL-WORLD, SINGLE-CENTER EXPERIENCE
Anno:
2025
Backgroud: Cardiogenic shock (CS) is a clinical syndrome defined by tissue hypoperfusion due to low cardiac output. It is characterized by extreme heterogeneity in etiologies, severity, and underlying pathophysiology. Phenotypes in CS population identified using unsupervised machine learning clustering methods have been proposed, potentially facilitating understanding the underlying pathophysiology,…
Leggi di più
THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A SAFE AND EFFECTIVE OPTION FOR HIGH-RISK AND IMMUNOCOMPROMISED PATIENTS
Anno:
2025
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is becoming increasingly recognized as a first-line choice for patients who are frail or immunocompromised, offering effective protection against sudden cardiac death while minimizing infection risk. Numerous studies, such as the ATLAS and PRAETORIAN randomized controlled trials, have demonstrated that the S-ICD is…
Leggi di più
Clinical evaluation, symptomatology and hospitalization for patients with heart failure taken in charge in an out-of-hospital care pathway.
Anno:
2025
Background: Our aim was to assess the changes in patients diagnosed with HF in terms of quality of life, symptoms, hospital admissions and therapeutic adherence when taken in an extra-hospital therapeutic care path. Methods:  From January 23 to September 24, our cardiology clinic treated 192 patients diagnosed with heart failure. Among…
Leggi di più
LEFT ATRIAL FILLING INDEX IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM INVASIVE HAEMODYNAMIC ASSESSMENT AND ADVANCED ECHOCARDIOGRAPHY
Anno:
2025
Background. Haemodynamics of patients with heart failure (HF) with reduced ejection fraction (HFrEF) is often characterised by increased left ventricular (LV) filling pressures. Non-invasive estimation of pulmonary artery wedge pressure (PAWP) is useful in the clinical management of these patients. The left atrial (LA) filling index could help estimate…
Leggi di più
CLINICAL CHARACTERISTICS AND PREDICTORS OF SUCCESSFUL DECONGESTION IN PATIENTS WITH ACUTE HEART FAILURE: DATA FROM THE NATIONWIDE BRING-UP3 HF STUDY
Anno:
2025
Introduction: Acute heart failure (AHF) is a critical condition requiring prompt intervention to alleviate fluid overload to reduce morbidity and mortality. However, there is still limited evidence on predictors of a successful decongestion at discharge. Purpose: To identify predictors of successful decongestion at discharge in patients hospitalized with AHF….
Leggi di più
ACUTE HEART FAILURE INDUCED BY FLECAINIDE: A CASE OF REVERSIBLE BIVENTRICULAR DYSFUNCTION
Anno:
2025
Flecainide is an effective antiarrhythmic agent for atrial fibrillation (AF) cardioversion, particularly in patients without significant structural heart disease. However, it may cause hemodynamic compromise in patients with left ventricular dysfunction. A 71-year-old man presented to the emergency department with worsening dyspnea and asthenia two days after undergoing electrical…
Leggi di più
CARDIAC REVERSE REMODELING AFTER CARDIAC RESYNCHRONIZATION THERAPY
Anno:
2025
CLINICAL CASE PRESENTATION A 62-year-old female smoker went to the emergency room for ankle swelling. ECG showed sinus tachycardia, left bundle branch block (LBBB) and non-sustained ventricular tachycardias. Blood test revealed a mild elevation of high sensitivity cardiac troponin I (31 ng/L) and a remarkable elevation of amino-terminal pro-B-type natriuretic…
Leggi di più
CARDIAC RESYNCHRONIZATION THERAPY WITH BIVENTRICULAR PACING OR LEFT BUNDLE BRANCH PACING: A PROSPECTIVE REGISTRY
Anno:
2025
Background: Cardiac resynchronization therapy (CRT) with biventricular pacing (BiVP) is an established treatment for heart failure (HF) with reduced ejection fraction (HFrEF) and wide QRS complexes, is effective in improving outcomes in patients who develop HF as a consequence of right ventricular pacing, and is indicated for patients with…
Leggi di più
DISCHARGE MEDICAL TREATMENT IMPLEMENTATION IN PATIENTS ADMITTED FOR AHF: PRELIMINARY DATA FROM THE BRING-UP3 HF STUDY
Anno:
2025
Background: Recent ESC guidelines introduced a new treatment paradigm for HFrEF, with a novel four pillar therapeutic approach comprising ACE-I/ARBs/ARNIs, Beta-blockers, MRAs, and SGLT2i. Furthermore, these guidelines for the first time give a Class IA recommendation for Empagliflozin and Dapagliflozin in HFmrEF and HFpEF. Evaluation of transferability of RCTs…
Leggi di più
A CASE OF FULMINANT MYOCARDITIS: THE IMPORTANCE OF EVERY DETAIL FOR EARLY TREATMENT. THE ECG AS A KEY TOOL IN EARLY DIAGNOSIS AND PROGNOSTIC STRATIFICATION
Anno:
2025
We report the case of a 67-year-old male who presented to a spoke emergency department with marked asthenia and dyspnea following an episode of acute gastroenteritis. Upon triage, the patient was assigned a red code due to hypotension and signs of hypoperfusion. Initial arterial blood gas analysis revealed metabolic…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram